Neoantigen architectures define immunogenicity and drive immune evasion of tumors with heterogenous neoantigen expression
Malte Roerden(Massachusetts Institute of Technology), Stefani Spranger(University of Chicago), Yufei Cui(Rice University), Kevin Litchfield(Cancer Research UK), Jonathan Dye(Massachusetts Institute of Technology), Laura Maiorino(Howard Hughes Medical Institute), Andrea Castro(Cancer Research UK), Byungji Kim(University of California San Diego), Darrell J. Irvine(Howard Hughes Medical Institute), Noora Harake(Massachusetts Institute of Technology), Forest M. White(Center for Cancer Research)
Cited by 21
Related Papers
Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae
|Nature Biotechnology|2002|1.6k
How many human proteoforms are there?
|Nature Chemical Biology|2018|945
Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition
|Cell|2021|875
Impact of oncogenic pathways on evasion of antitumour immune responses
|Nature reviews. Cancer|2018|652